Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katharine Floyd

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Biorxiv : the Preprint Server for Biology|April 1, 2021
Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ SubjectsMadeleine F Jennewein, Anna J MacCamy, Nicholas R Akins, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variantVenkata-Viswanadh Edara, Kelly E Manning, Madison Ellis, et al.
Cell Host & Microbe|April 2, 2021
Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variantVenkata Viswanadh Edara, Carson Norwood, Katharine Floyd, et al.
Cell Reports. Medicine|July 12, 2021
Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cellsKristen W Cohen, Susanne L Linderman, Zoe Moodie, et al.
Immunity|February 25, 2021
A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungsNanda Kishore Routhu, Narayanaiah Cheedarla, Sailaja Gangadhara, et al.
Medrxiv : the Preprint Server for Health Sciences|May 5, 2021
Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cellsKristen W Cohen, Susanne L Linderman, Zoe Moodie, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2021
Reduced binding and neutralization of infection- and vaccine-induced antibodies to the B.1.351 (South African) SARS-CoV-2 variantVenkata Viswanadh Edara, Carson Norwood, Katharine Floyd, et al.
Medrxiv : the Preprint Server for Health Sciences|January 12, 2022
Antibody response to SARS-CoV-2 mRNA vaccine in lung cancer patients: Reactivity to vaccine antigen and variants of concernRajesh Valanparambil, Jennifer Carlisle, Susanne Linderman, et al.
Medrxiv : the Preprint Server for Health Sciences|December 21, 2021
Booster of mRNA-1273 Strengthens SARS-CoV-2 Omicron NeutralizationNicole A Doria-Rose, Xiaoying Shen, Stephen D Schmidt, et al.
The New England Journal of Medicine|September 29, 2020
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older AdultsEvan J Anderson, Nadine G Rouphael, Alicia T Widge, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Biorxiv : the Preprint Server for Biology|April 1, 2021
Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ SubjectsMadeleine F Jennewein, Anna J MacCamy, Nicholas R Akins, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variantVenkata-Viswanadh Edara, Kelly E Manning, Madison Ellis, et al.
Cell Host & Microbe|April 2, 2021
Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variantVenkata Viswanadh Edara, Carson Norwood, Katharine Floyd, et al.
Cell Reports. Medicine|July 12, 2021
Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cellsKristen W Cohen, Susanne L Linderman, Zoe Moodie, et al.
Immunity|February 25, 2021
A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungsNanda Kishore Routhu, Narayanaiah Cheedarla, Sailaja Gangadhara, et al.
Medrxiv : the Preprint Server for Health Sciences|May 5, 2021
Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cellsKristen W Cohen, Susanne L Linderman, Zoe Moodie, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2021
Reduced binding and neutralization of infection- and vaccine-induced antibodies to the B.1.351 (South African) SARS-CoV-2 variantVenkata Viswanadh Edara, Carson Norwood, Katharine Floyd, et al.
Medrxiv : the Preprint Server for Health Sciences|January 12, 2022
Antibody response to SARS-CoV-2 mRNA vaccine in lung cancer patients: Reactivity to vaccine antigen and variants of concernRajesh Valanparambil, Jennifer Carlisle, Susanne Linderman, et al.
Medrxiv : the Preprint Server for Health Sciences|December 21, 2021
Booster of mRNA-1273 Strengthens SARS-CoV-2 Omicron NeutralizationNicole A Doria-Rose, Xiaoying Shen, Stephen D Schmidt, et al.
The New England Journal of Medicine|September 29, 2020
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older AdultsEvan J Anderson, Nadine G Rouphael, Alicia T Widge, et al.
Pageof 4